South Korea
· Delayed Price · Currency is KRW EuBiologics Company Description
EuBiologics Co., Ltd., a biopharmaceutical company, provides vaccines for pidemics in South Korea.
It offers Euvichol, Euvichol Plus, and Euvichol-S, an oral cholera vaccine developed to prevent cholera; and EuCorVac-19, a subunit vaccine.The company also provides EcML, a vaccine for cell membrane, as well as offers COVID-19 diagnostic kits; and rCRM197, a diphtheria toxoid vaccine.
In addition, it offers CMO services comprising of drug product production, cell bank production, drug product production, and drug substance production.
Further, the company provides CRMO services, including production process development, formulation development, analyticals method development, and licensing and approval consulting service; and operates facilities that manufacture protein-based therapeutics and antibodies.
Additionally, it offers contract testing services that include lot release, stability, raw material, and method validation testing services.
EuBiologics Co., Ltd. was founded in 2010 and is headquartered in Seoul, South Korea.
| Country | South Korea |
| Founded | 2010 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Yeong-Ok Baik |
Contact Details
Address: 509, Dosan-daero Seoul South Korea | |
| Phone | 82 2 572 6675 |
| Website | eubiologics.com |
Stock Details
| Ticker Symbol | 206650 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7206650004 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Yeong-Ok Baik | Chief Executive Officer |